The Sodium-Iodide Symporter (NIS): NIS-Mediated Radioiodide Therapy

Christine Spitzweg, John C. Morris

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The sodium iodide symporter (NIS) is an intrinsic plasma membrane glycoprotein that mediates the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in particular the lactating mammary gland. In addition to its key function in thyroid physiology, NIS-mediated iodide accumulation allows diagnostic thyroid scintigraphy, as well as therapeutic radioiodine application in benign and malignant thyroid disease. NIS therefore represents one of the oldest targets for molecular imaging and therapy. Cloning and characterization of the NIS gene has paved the way for the development of a novel cytoreductive gene therapy strategy based on targeted NIS expression in thyroidal and nonthyroidal cancer cells followed by therapeutic application of 131I or alternative radionuclides, including 188Re and 211At. In addition, the possibility of direct and noninvasive imaging of functional NIS expression by 123I and 99mTc scintigraphy or 124I-PET imaging allows the application of NIS as a novel reporter gene. The dual role of NIS as a diagnostic and therapeutic gene and the detection of extrathyroidal endogenous NIS expression in breast cancer open promising perspectives in nuclear medicine and molecular oncology for diagnostic and therapeutic application of NIS outside the thyroid gland.

Original languageEnglish (US)
Title of host publicationComprehensive Handbook of Iodine
PublisherElsevier Inc.
Pages979-989
Number of pages11
ISBN (Print)9780123741356
DOIs
StatePublished - 2009

Fingerprint

symporters
iodides
sodium
Thyroid Gland
therapeutics
scintigraphy
thyroid gland
Iodides
Radionuclide Imaging
image analysis
thyroid diseases
membrane glycoproteins
Therapeutics
positron-emission tomography
thyroid function
Molecular Imaging
active transport
gene therapy
Molecular Pathology
Active Biological Transport

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)

Cite this

Spitzweg, C., & Morris, J. C. (2009). The Sodium-Iodide Symporter (NIS): NIS-Mediated Radioiodide Therapy. In Comprehensive Handbook of Iodine (pp. 979-989). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374135-6.00101-1

The Sodium-Iodide Symporter (NIS) : NIS-Mediated Radioiodide Therapy. / Spitzweg, Christine; Morris, John C.

Comprehensive Handbook of Iodine. Elsevier Inc., 2009. p. 979-989.

Research output: Chapter in Book/Report/Conference proceedingChapter

Spitzweg, C & Morris, JC 2009, The Sodium-Iodide Symporter (NIS): NIS-Mediated Radioiodide Therapy. in Comprehensive Handbook of Iodine. Elsevier Inc., pp. 979-989. https://doi.org/10.1016/B978-0-12-374135-6.00101-1
Spitzweg C, Morris JC. The Sodium-Iodide Symporter (NIS): NIS-Mediated Radioiodide Therapy. In Comprehensive Handbook of Iodine. Elsevier Inc. 2009. p. 979-989 https://doi.org/10.1016/B978-0-12-374135-6.00101-1
Spitzweg, Christine ; Morris, John C. / The Sodium-Iodide Symporter (NIS) : NIS-Mediated Radioiodide Therapy. Comprehensive Handbook of Iodine. Elsevier Inc., 2009. pp. 979-989
@inbook{cf3f68ba0f224a0695cbc46c5297db98,
title = "The Sodium-Iodide Symporter (NIS): NIS-Mediated Radioiodide Therapy",
abstract = "The sodium iodide symporter (NIS) is an intrinsic plasma membrane glycoprotein that mediates the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in particular the lactating mammary gland. In addition to its key function in thyroid physiology, NIS-mediated iodide accumulation allows diagnostic thyroid scintigraphy, as well as therapeutic radioiodine application in benign and malignant thyroid disease. NIS therefore represents one of the oldest targets for molecular imaging and therapy. Cloning and characterization of the NIS gene has paved the way for the development of a novel cytoreductive gene therapy strategy based on targeted NIS expression in thyroidal and nonthyroidal cancer cells followed by therapeutic application of 131I or alternative radionuclides, including 188Re and 211At. In addition, the possibility of direct and noninvasive imaging of functional NIS expression by 123I and 99mTc scintigraphy or 124I-PET imaging allows the application of NIS as a novel reporter gene. The dual role of NIS as a diagnostic and therapeutic gene and the detection of extrathyroidal endogenous NIS expression in breast cancer open promising perspectives in nuclear medicine and molecular oncology for diagnostic and therapeutic application of NIS outside the thyroid gland.",
author = "Christine Spitzweg and Morris, {John C.}",
year = "2009",
doi = "10.1016/B978-0-12-374135-6.00101-1",
language = "English (US)",
isbn = "9780123741356",
pages = "979--989",
booktitle = "Comprehensive Handbook of Iodine",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - The Sodium-Iodide Symporter (NIS)

T2 - NIS-Mediated Radioiodide Therapy

AU - Spitzweg, Christine

AU - Morris, John C.

PY - 2009

Y1 - 2009

N2 - The sodium iodide symporter (NIS) is an intrinsic plasma membrane glycoprotein that mediates the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in particular the lactating mammary gland. In addition to its key function in thyroid physiology, NIS-mediated iodide accumulation allows diagnostic thyroid scintigraphy, as well as therapeutic radioiodine application in benign and malignant thyroid disease. NIS therefore represents one of the oldest targets for molecular imaging and therapy. Cloning and characterization of the NIS gene has paved the way for the development of a novel cytoreductive gene therapy strategy based on targeted NIS expression in thyroidal and nonthyroidal cancer cells followed by therapeutic application of 131I or alternative radionuclides, including 188Re and 211At. In addition, the possibility of direct and noninvasive imaging of functional NIS expression by 123I and 99mTc scintigraphy or 124I-PET imaging allows the application of NIS as a novel reporter gene. The dual role of NIS as a diagnostic and therapeutic gene and the detection of extrathyroidal endogenous NIS expression in breast cancer open promising perspectives in nuclear medicine and molecular oncology for diagnostic and therapeutic application of NIS outside the thyroid gland.

AB - The sodium iodide symporter (NIS) is an intrinsic plasma membrane glycoprotein that mediates the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in particular the lactating mammary gland. In addition to its key function in thyroid physiology, NIS-mediated iodide accumulation allows diagnostic thyroid scintigraphy, as well as therapeutic radioiodine application in benign and malignant thyroid disease. NIS therefore represents one of the oldest targets for molecular imaging and therapy. Cloning and characterization of the NIS gene has paved the way for the development of a novel cytoreductive gene therapy strategy based on targeted NIS expression in thyroidal and nonthyroidal cancer cells followed by therapeutic application of 131I or alternative radionuclides, including 188Re and 211At. In addition, the possibility of direct and noninvasive imaging of functional NIS expression by 123I and 99mTc scintigraphy or 124I-PET imaging allows the application of NIS as a novel reporter gene. The dual role of NIS as a diagnostic and therapeutic gene and the detection of extrathyroidal endogenous NIS expression in breast cancer open promising perspectives in nuclear medicine and molecular oncology for diagnostic and therapeutic application of NIS outside the thyroid gland.

UR - http://www.scopus.com/inward/record.url?scp=84884441340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884441340&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374135-6.00101-1

DO - 10.1016/B978-0-12-374135-6.00101-1

M3 - Chapter

AN - SCOPUS:84884441340

SN - 9780123741356

SP - 979

EP - 989

BT - Comprehensive Handbook of Iodine

PB - Elsevier Inc.

ER -